Announced Wed, 8 Jul · 19:08 IST
Compliance certificate for securities dematerialisation filed for Q1 FY27
Compliance View source PDF
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹1079.90
prior close
₹1081.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.5+0.7+1.0+0.3-0.6-0.5-1.8-3.1-2.3————
Up moveDown movePending
AI summary
Strides Pharma Science has submitted a compliance certificate from its registrar KFin Technologies under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate confirms details of securities dematerialised and rematerialised during the quarter have been furnished to NSE and BSE. This is a routine procedural filing required every quarter.
Likely market impact
No material impact. Routine regulatory compliance filing with no effect on business, financials, or share price.